Huffington Post features CN Bio CEO:

Women in Innovation: Developing ‘Organs-on-Chips’

Interview clip:

“My background as a chemist means that I like precision. However, drug development is not nearly as logical as we’d like. Profound uncertainty about the likely success of drug programs can persist into late stage clinical trials – by which time millions of pounds will have already been spent. At CN Bio we were determined to find a better way, a way of modelling how a drug would work on human cells which could be safely tested in a laboratory setting.”

← Back To All News


We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
By submitting your message, you acknowledge that you have read and understood the Privacy Policy

I confirm that I would like CN Bio to stay in touch

We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
By submitting your message, you acknowledge that you have read and understood the Privacy Policy

I confirm that I would like CN Bio to stay in touch

We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
By submitting your message, you acknowledge that you have read and understood the Privacy Policy

I confirm that I would like CN Bio to stay in touch